Moxifloxacin, Ofloxacin, Sparfloxacin, and Ciprofloxacin Against Mycobacterium Tuberculosis: Evaluation of in Vitro and Pharmacodynamic Indices That Best Predict in Vivo Efficacy
Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.00414-06
Full Text
Open PDFAbstract
Available in full text
Date
December 4, 2006
Authors
Publisher
American Society for Microbiology